Next Article in Journal
Bone Metabolism and RANKL/OPG Ratio in Rheumatoid Arthritis Women Treated with TNF-α Inhibitors
Previous Article in Journal
Is Shear-Wave Elastography a Clinical Severity Indicator of Myofascial Pain Syndrome? An Observational Study
Previous Article in Special Issue
Application of Telehealth in Prenatal Care during the COVID-19 Pandemic—A Cross-Sectional Survey of Polish Women
Review

ISIDOG Consensus Guidelines on COVID-19 Vaccination for Women before, during and after Pregnancy

1
Femicare VZW Clinical Research for Women, 3300 Tienen, Belgium
2
Department Obstetrics and Gynecology, University Hospital Antwerp, 2650 Edegem, Belgium
3
President International Society Infectious Diseases (ISIDOG), 3300 Tienen, Belgium
4
Department Biothemodynamics and Drug Design, Institute of Biotechnology and Life Sciences Center, Vilnius University, 01513 Vilnius, Lithuania
5
East Tallin Central Hospital Women’s Clinic, 10138 Tallin, Estonia
6
Department Gynecology, Hospital St Olav, 7030 Trondheim, Norway
7
LETO-Obstetrician Gynecological & Surgical Center, Department Obstetrics and Gynecology, 11525 Athens, Greece
8
Medisch Centrum Alkmaar, Department Obstetrics and Gynecology, 1814 Alkmaar, The Netherlands
9
Department Obstetrics and Gynecology, Universidade da Beira Interior, 6201-001 Covilha, Portugal
10
Department Obstetrics and Gynecology, University of Kansas Medical Center, Kansas City, KS 66160, USA
11
German Center for Infections in Obstetrics and Gynceology, Department Obstetrics and Gynecology, 42283 Wupperthal, Germany
*
Author to whom correspondence should be addressed.
Membership of the COVID-19 ISIDOG Guideline Group is provided in the Acknowledgments.
Academic Editor: Gabriele Tonni
J. Clin. Med. 2021, 10(13), 2902; https://doi.org/10.3390/jcm10132902
Received: 19 April 2021 / Revised: 17 June 2021 / Accepted: 22 June 2021 / Published: 29 June 2021
Introduction. Sars-CoV-2 infection poses particular problems in pregnancy, as the infection more frequently causes severe complications than in unaffected pregnant women or nonpregnant women with SARS-CoV-2 infection. Now that vaccination is available and rapidly being implemented worldwide, the question arises whether pregnant women should be vaccinated, and if so, whether they should receive priority. Methods. Available scientific data and available guidelines about vaccination against SARS-CoV-2 were collected by the Guideline Committee of the International Society of Infectious Diseases in Obstetrics and Gynecology (ISIDOG) and were analyzed, discussed and summarized as guidelines for healthcare workers caring for pregnant women. Concluding statements were graded according to the Oxford evidence-based medicine grading system. Results. There is evidence to consider pregnancy as a risk factor for serious complications of COVID-19 infection, even in the absence of additional risk factors, such as hypertension, diabetes and obesity which increase these risks even more in pregnancy. Currently available data slightly favor mRNA-based vaccines above vector-based vaccines during pregnancy and breastfeeding, until more safety data become available. Conclusion. ISIDOG advises policy makers and societies to prioritize pregnant women to receive vaccination against SARS-CoV-2 and favor the mRNA vaccines until further safety information becomes available. View Full-Text
Keywords: vaccine; pregnancy complication; SARS-CoV-2; COVID-19; maternal complications; pandemic; prevention; safety vaccine; pregnancy complication; SARS-CoV-2; COVID-19; maternal complications; pandemic; prevention; safety
MDPI and ACS Style

Donders, G.G.G.; Grinceviciene, S.; Haldre, K.; Lonnee-Hoffmann, R.; Donders, F.; Tsiakalos, A.; Adriaanse, A.; Martinez de Oliveira, J.; Ault, K.; Mendling, W.; on the behalf of the COVID-19 ISIDOG Guideline Group. ISIDOG Consensus Guidelines on COVID-19 Vaccination for Women before, during and after Pregnancy. J. Clin. Med. 2021, 10, 2902. https://doi.org/10.3390/jcm10132902

AMA Style

Donders GGG, Grinceviciene S, Haldre K, Lonnee-Hoffmann R, Donders F, Tsiakalos A, Adriaanse A, Martinez de Oliveira J, Ault K, Mendling W, on the behalf of the COVID-19 ISIDOG Guideline Group. ISIDOG Consensus Guidelines on COVID-19 Vaccination for Women before, during and after Pregnancy. Journal of Clinical Medicine. 2021; 10(13):2902. https://doi.org/10.3390/jcm10132902

Chicago/Turabian Style

Donders, Gilbert G.G., Svitrigaile Grinceviciene, Kai Haldre, Risa Lonnee-Hoffmann, Francesca Donders, Aristotelis Tsiakalos, Albert Adriaanse, José Martinez de Oliveira, Kevin Ault, Werner Mendling, and on the behalf of the COVID-19 ISIDOG Guideline Group. 2021. "ISIDOG Consensus Guidelines on COVID-19 Vaccination for Women before, during and after Pregnancy" Journal of Clinical Medicine 10, no. 13: 2902. https://doi.org/10.3390/jcm10132902

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop